Mera Pharmaceuticals Inc
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari's system of martial arts. In addition, it provides foo… Read more
Mera Pharmaceuticals Inc (MRPI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2011: 0.083x
Based on the latest financial reports, Mera Pharmaceuticals Inc (MRPI) has a cash flow conversion efficiency ratio of 0.083x as of October 2011.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-72.19K) by net assets ($-864.62K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mera Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1996–2011)
This chart illustrates how Mera Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Mera Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mera Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Equal Trading Inc
PINK:EQTD
|
-0.012x |
|
Foy Johnston Inc
PINK:FOYJ
|
-5.765x |
|
Alliance Media Holdings Inc
PINK:ADTR
|
-0.047x |
|
WellQuest Medical & Wellness Corporation
PINK:WEQL
|
-0.003x |
|
Green Cures & Botanical Distribution Inc
PINK:GRCU
|
-0.021x |
|
Global Environmental Energy Corp
PINK:GEECF
|
-0.009x |
|
Flameret Inc
PINK:FLRE
|
0.000x |
|
International Silver Inc
PINK:ISLV
|
-0.014x |
Annual Cash Flow Conversion Efficiency for Mera Pharmaceuticals Inc (1996–2011)
The table below shows the annual cash flow conversion efficiency of Mera Pharmaceuticals Inc from 1996 to 2011.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2011-10-31 | $-864.62K | $-71.84K | 0.083x | +757.44% |
| 2010-10-31 | $-676.94K | $8.55K | -0.013x | -106.65% |
| 2009-10-31 | $-139.10K | $-26.45K | 0.190x | +108.62% |
| 2008-10-31 | $53.78K | $-118.59K | -2.205x | -8925.67% |
| 2007-10-31 | $1.81 Million | $-44.33K | -0.024x | +75.95% |
| 2006-10-31 | $2.00 Million | $-202.67K | -0.102x | +59.98% |
| 2005-10-31 | $2.24 Million | $-567.49K | -0.254x | +40.25% |
| 2004-10-31 | $2.94 Million | $-1.25 Million | -0.425x | +22.57% |
| 2003-10-31 | $1.98 Million | $-1.09 Million | -0.549x | +6.70% |
| 2002-10-31 | $641.38K | $-377.15K | -0.588x | -108.87% |
| 2001-10-31 | $-457.95K | $-3.04 Million | 6.631x | +218.57% |
| 2000-10-31 | $597.67K | $-3.34 Million | -5.593x | +12.62% |
| 1999-10-31 | $500.00K | $-3.20 Million | -6.400x | -402.45% |
| 1998-10-31 | $1.07 Million | $-1.37 Million | -1.274x | -106.84% |
| 1997-10-31 | $-106.55K | $-1.98 Million | 18.616x | +1252.94% |
| 1996-10-31 | $290.80K | $-469.53K | -1.615x | -- |